CONCOMITANT ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA-2A IN CANCER-PATIENTS - A PHASE-I STUDY

被引:91
作者
LEE, KH
TALPAZ, M
ROTHBERG, JM
MURRAY, JL
PAPADOPOULOS, N
PLAGER, C
BENJAMIN, R
LEVITT, D
GUTTERMAN, J
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED ONCOL,HOUSTON,TX 77030
[3] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110
关键词
D O I
10.1200/JCO.1989.7.11.1726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1726 / 1732
页数:7
相关论文
共 30 条
  • [21] ANTITUMOR-ACTIVITY OF RECOMBINANT-DERIVED INTERFERON-ALPHA IN METASTATIC RENAL-CELL CARCINOMA
    QUESADA, JR
    RIOS, A
    SWANSON, D
    TROWN, P
    GUTTERMAN, JU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) : 1522 - 1528
  • [22] QUESADA JR, 1983, CANCER RES, V43, P940
  • [23] TREATMENT OF HAIRY-CELL LEUKEMIA WITH RECOMBINANT ALPHA-INTERFERON
    QUESADA, JR
    HERSH, EM
    MANNING, J
    REUBEN, J
    KEATING, M
    SCHNIPPER, E
    ITRI, L
    GUTTERMAN, JU
    [J]. BLOOD, 1986, 68 (02) : 493 - 497
  • [24] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
    ROSENBERG, SA
    LOTZE, MT
    MUUL, LM
    CHANG, AE
    AVIS, FP
    LEITMAN, S
    LINEHAN, WM
    ROBERTSON, CN
    LEE, RE
    RUBIN, JT
    SEIPP, CA
    SIMPSON, CG
    WHITE, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) : 889 - 897
  • [25] OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
    ROSENBERG, SA
    LOTZE, MT
    MUUL, LM
    LEITMAN, S
    CHANG, AE
    ETTINGHAUSEN, SE
    MATORY, YL
    SKIBBER, JM
    SHILONI, E
    VETTO, JT
    SEIPP, CA
    SIMPSON, C
    REICHERT, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) : 1485 - 1492
  • [26] REGRESSION OF ESTABLISHED PULMONARY METASTASES AND SUBCUTANEOUS TUMOR MEDIATED BY THE SYSTEMIC ADMINISTRATION OF HIGH-DOSE RECOMBINANT INTERLEUKIN-2
    ROSENBERG, SA
    MULE, JJ
    SPIESS, PJ
    REICHERT, CM
    SCHWARZ, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) : 1169 - 1188
  • [27] SONDEL PM, 1988, CANCER RES, V48, P2561
  • [28] REPETITIVE WEEKLY CYCLES OF RECOMBINANT HUMAN INTERLEUKIN-2 - RESPONSES OF RENAL-CARCINOMA WITH ACCEPTABLE TOXICITY
    SOSMAN, JA
    KOHLER, PC
    HANK, J
    MOORE, KH
    BECHHOFER, R
    STORER, B
    SONDEL, PM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) : 60 - 63
  • [29] HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT INDUCED BY RECOMBINANT HUMAN INTERFERON-ALPHA-A IN CHRONIC MYELOGENOUS LEUKEMIA
    TALPAZ, M
    KANTARJIAN, HM
    MCCREDIE, K
    TRUJILLO, JM
    KEATING, MJ
    GUTTERMAN, JU
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (17) : 1065 - 1069
  • [30] IMMUNOTHERAPY OF A MURINE TUMOR WITH INTERLEUKIN-2 - INCREASED SENSITIVITY AFTER MHC CLASS-I GENE TRANSFECTION
    WEBER, JS
    JAY, G
    TANAKA, K
    ROSENBERG, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (06) : 1716 - 1733